Efficacy of ibuprofen versus acetaminophen and conservative management for closure of patent ductus arteriosus in preterm neonates: a randomized clinical trial

Noor Mohammad Noori; Alireza Teimouri; Saeedeh Yaghoubi

doi:10.2478/rjc-2026-0012

.blurhash-client-img { display: none !important; }

Efficacy of ibuprofen versus acetaminophen and conservative management for closure of patent ductus arteriosus in preterm neonates: a randomized clinical trial

Romanian Journal of Cardiology

AHEAD OF PRINT

By: Noor Mohammad Noori, Alireza Teimouri and Saeedeh Yaghoubi

Open Access

|May 2026

Abstract

Background

Patent ductus arteriosus (PDA) is a common cause of morbidity and mortality in preterm neonates. This study aimed to compare the efficacy of ibuprofen with acetaminophen and conservative management in achieving PDA closure in preterm infants.

Methods

In this randomized clinical trial, 327 preterm neonates with a gestational age of less than 37 weeks and a birth weight under 2500 g were enrolled. Participants were randomly assigned to receive ibuprofen, acetaminophen, or conservative management without pharmacological treatment. Echocardiographic assessments were performed on the third postnatal day and repeated one day after completion of the treatment course to evaluate ductal closure. Statistical analyses were conducted using SPSS version 22.

Results

The 327 preterm neonates were evenly allocated to the acetaminophen, ibuprofen, and control groups. The PDA closure rate was significantly higher in both the acetaminophen (89.0%) and ibuprofen (94.5%) groups compared to the control group (71%) (p < 0.001 for both), with no significant difference between the two active drugs (p = 0.14). Similar patterns were observed for LA/Ao (left atrium-to-aortic root) ratio normalization. Subgroup analyses revealed that in infants born at ≥ 32 weeks of gestation, ibuprofen achieved a 100% closure rate, compared to 91.8% for acetaminophen (p = 0.05). Among infants weighing ≥ 1500 g, ibuprofen demonstrated significantly superior closure (98.6% vs. 91.1%, p = 0.04). However, in very low birth weight infants (<1500 g), neither active drug reached statistical significance over control.

Conclusion

Both pharmacologic agents were superior to conservative management, with ibuprofen showing enhanced efficacy over acetaminophen in more mature and heavier infants.

References

Noori NM, Teimouri A, Dehvari A, Bagheie S, Ansari H. The effect of oral acetaminophen on open arterial duct closure in premature infants less than 32 weeks. Romanian J Cardiol 2023; 33(2): 54-59. Available from URL: https://doi.org/10.2478/rjc-2023-0007
Search in Google Scholar Back to article
Chatziantoniou A, Rorris F-P, Samanidis G, Kanakis M. Keeping the ductus arteriosus patent: Current strategy and perspectives. Diagnostics 2025; 15(3):241. Available from URL: https://doi.org/10.3390/diagnostics15030241
Search in Google Scholar Back to article
Noori N, Yaghoubi S, Teimouri A. The evaluation of left atrial to aortic root diameter ratio after PDA closure in children. Int J Pediatr 2021; 9(11):14830-14841. DOI: 10.22038/IJP.2021.57769.4530
Open DOI Search in Google Scholar Back to article
Aguet J, Seed M, Marini D. Fetal cardiovascular magnetic resonance imaging. Pediatr Radiol 2020; 50:1881-94. Available from URL: https://doi.org/10.1007/s00247-020-04902-y
Search in Google Scholar Back to article
Doherty TM, Hu A, Salik I. Physiology, Neonatal. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan [cited 2 Mar 2026]. Available from URL: https://www.ncbi.nlm.nih.gov/books/NBK539840/
Search in Google Scholar Back to article
Spenard S, Backes C, Fitzgerald DA, Sant’Anna G, Altit G. Current approaches to the patent ductus arteriosus: implications for pulmonary morbidities. Paediatr Respir Rev 2025; S1526-0542(25)00057-0. doi: 10.1016/j.prrv.2025.05.001.
Open DOI Search in Google Scholar Back to article
Semberova J, Sirc J, Miletin J, Kucera J, Berka I, Sebkova S, et al. Spontaneous closure of patent ductus arteriosus in infants ≤ 1500 g. Pediatrics 2017; 140(2): e20164258. Available from URL: https://doi.org/10.1542/peds.2016-4258
Search in Google Scholar Back to article
Philip R, Towbin JA, Sathanandam S, Goldberg J, Yohannan T, Swaminathan N, et al. Effect of patent ductus arteriosus on the heart in preterm infants. Congenit Heart Dis 2019; 14(1):33-6. Available from URL: https://doi.org/10.1111/chd.12701
Search in Google Scholar Back to article
Mitra S, Jain A, Ting JY, Fadel NB, Drolet C, AbouMehrem A, et al, Dorling J. Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA). BMJ Open 2021; 11(5):e050682. Available from URL: https://doi.org/10.1136/bmjopen-2021-050682
Search in Google Scholar Back to article
Ahranjani B, Dalili H, Nashtifani Z, et al. The comparison between intravenous acetaminophen versus oral ibuprofen in preterm newborns with patent ductus arteriosus: aAclinical trial. Acta Med Iran 2021; 58(12):631-636.
Search in Google Scholar Back to article
Aikio O, Härkin P, Saarela T, et al. Early paracetamol treatment associated with lowered risk of persistent ductus arteriosus in very preterm infants. J. Matern.-Fetal Neonatal Med 2014; 27(12):1252-6. Available from URL: https://doi.org/10.3109/14767058.2013.854327
Search in Google Scholar Back to article
Terrin G, Conte F, Oncel MY, Scipione A, McNamara PJ, Simons S, et al. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2016; 101(2):F127-36. Available from URL: https://doi.org/10.1136/archdischild-2014-307312
Search in Google Scholar Back to article
Härkin P, Härmä A, Aikio O, Valkama M, Leskinen M, Saarela T, et al. Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial. J Pediatr 2016; 177:72-7. https://doi.org/10.1016/j. jpeds.2016.04.066
Search in Google Scholar Back to article
Höck M, Brunner B, Rier V, Thöni S, Trawöger R, Geiger R, et al. Prophylactic low-dose paracetamol administration associated with lowered rate of patent ductus arteriosus in preterm infants-impact on outcome and pain perception. Pediatr Neonatol 2020; 61(1):84-91. Available from URL: https://doi.org/10.1016/j.pedneo.2019.06.011
Search in Google Scholar Back to article
Dash SK, Kabra NS, Avasthi BS, Sharma SR, Padhi P, Ahmed J. Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized controlled trial. Indian Pediatr 2015; 52:573-8. Available from URL: https://doi.org/10.1007/s13312-015-0677-z
Search in Google Scholar Back to article
Bagheri MM, Bahman-Bijari B, Torabi-Nejad MH, Niknafs P, Mousavi H, Sabzevari F, et al. Is prophylactic parenteral paracetamol effective to diminish incidence of PDA in preterm neonates? A randomized trial. Iran J Pediatr 2018; 28(4). Available from URL: https://doi.org/10.5812/ijp.11735
Search in Google Scholar Back to article
Schindler T, Smyth J, Bolisetty S, Michalowski J, Mallitt KA, Singla A, et al. Early PARacetamol (EPAR) trial: A randomized controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants. Neonatology 2021; 118(3):274-81. Available from URL: https://doi.org/10.1159/000515415
Search in Google Scholar Back to article
Surak A, Jain A and Hyderi A. Different approaches for patent ductus arteriosus in premature infants using acetaminophen. World J Pediatr 2022; 18:243-250. Available from URL: https://doi.org/10.1007/s12519-022-00526-4
Search in Google Scholar Back to article
Iacobelli S, Lorrain S, Gouyon B, Gambacorta S, Laforgia N, Gouyon JB, et al. Drug exposure for PDA closure in France: a prospective, cohortbased, analysis. European J Clin Pharmacol 2020; 76:1765-72. Available from URL: https://doi.org/10.1007/s00228-020-02974-1
Search in Google Scholar Back to article
Asbagh PA, Zarkesh MR, Nili F, Nayeri FS, Tofighi Naeem AT. Prophylactic treatment with oral paracetamol for patent ductus arteriosus in preterm infants: A randomized clinical trial. Tehran Univ Med J 2015; 73(2):86-92.
Search in Google Scholar Back to article
Jasani B, Mitra S, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev 2018(4). Available from URL: https://doi.org/10.1002/14651858. CD010061.pub5.
Search in Google Scholar Back to article
Hillier K, Jones K, MacInnis M, Mitra S. Comparison of standard versus high-dose ibuprofen for the treatment of hemodynamically significant patent ductus arteriosus in preterm infants. J Perinatol 2021; 41(5):1142-1148. doi: 10.1038/s41372-021-01046-1.
Open DOI Search in Google Scholar Back to article
Dani C, Lista G, Bianchi S, Mosca F, Schena F, Ramenghi L, et al. Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: A randomized controlled trial. Eur J Pediatr 2021; 180(3):807-16. Available from URL: https://doi.org/10.1007/s00431-020-03780-8
Search in Google Scholar Back to article
Balachander B, Mondal N, Bhat V, Adhisivam B, Kumar M, Satheesh S, et al. Comparison of efficacy of oral paracetamol versus ibuprofen for PDA closure in preterms - a prospective randomized clinical trial. J Matern Fetal Neonatal Med 2020; 33(9):1587-92. Available from URL: https://doi.org/10.1080/14767058.2018.1525354
Search in Google Scholar Back to article
Yang B, Gao X, Ren Y, Wang Y, Zhang Q. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial. Exp Ther Med 2016; 12(4):2531-6. Available from URL: https://doi.org/10.3892/etm.2016.3676
Search in Google Scholar Back to article
Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 2014; 164(3):510-4. Available from URL: https://doi.org/10.1016/j.jpeds.2013.11.008
Search in Google Scholar Back to article
Gonzalez-Luis G, Borges-Lujan M, Villamor E. Association between endotypes of prematurity and pharmacological closure of patent ductus arteriosus: A systematic review and meta-analysis. medRxiv 2022; 2022-10. Available from URL: https://doi.org/10.1101/2022.10.24.22281438
Search in Google Scholar Back to article
Nemerofsky SL, Parravicini E, Bateman D, Kleinman C, Polin RA, Lorenz JM. The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol 2008; 25(10):661-6. Available from URL: https://doi.org/10.1055/s-0028-1090594
Search in Google Scholar Back to article
Herrman K, Bose C, Lewis K. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 2009; 94(1):F48-50. Available from URL: https://doi.org/10.1136/adc.2007.129270
Search in Google Scholar Back to article
Hamrick SE, Sallmon H, Rose AT, Porras D, Shelton EL, Reese J, et al. Patent ductus arteriosus of the preterm infant. Pediatrics 2020 Nov 1;146(5). Available from URL: https://doi.org/10.1542/peds.2020-1209
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.2478/rjc-2026-0012 | Journal eISSN: 2734-6382 | Journal ISSN: 1220-658X

Journal RSS Feed

Language: English

Published on: May 29, 2026

Published by: Romanian Society of Cardiology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Acetaminophen,

Ibuprofen,

Patent ductus arteriosus,

Preterm neonates,

Randomized clinical trial

Related subjects:

Surgery,

Pediatrics and juvenile medicine,

Paediatric cardiology

© 2026 Noor Mohammad Noori, Alireza Teimouri, Saeedeh Yaghoubi, published by Romanian Society of Cardiology
This work is licensed under the Creative Commons Attribution 4.0 License.

AHEAD OF PRINT